Assembly biosciences to present new data at aasld the liver meeting®

-- one poster and one oral presentation selected, with the poster highlighting new preclinical data from the company's interferon-Α receptor agonist program -- south san francisco, oct. 11, 2023 (globe newswire) -- assembly biosciences, inc. (nasdaq: asmb), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that preclinical and clinical data from its virology portfolio will be featured in two presentations at the upcoming american association for the study of liver diseases (aasld), the liver meeting®, taking place november 10-14, 2023, in boston.
ASMB Ratings Summary
ASMB Quant Ranking